Shreya Saraf

Shreya joined Health Advances in 2018 and brings experience in commercial due diligence, forecasting, portfolio prioritization, and market and policy assessments across biopharma and digital health.

Prior to joining Health Advances, Shreya was a Summer Associate in Pipeline and Portfolio Planning at Genentech, a Strategy and Business Development Manager at Cipla Ltd., and an Associate at Boston Consulting Group (BCG).

Shreya holds an MBA from Harvard Business School, an MS in Biotechnology from Johns Hopkins University, an M.Phil. in Chemistry from the University of Cambridge, and a BA in Chemistry from Pomona College.